CEO Doron Blachar is optimistic about the new assets enhancing Ormat's profits and is eager to increase shareholder value. The deal underscores Ormat's leadership in renewable energy and its commitment to global renewable power solutions.
Insiders at Ormat Technologies' mass stock selling over the past year may suggest a lack of confidence in future performance. Low insider ownership and a continued lack of insider buying is concerning.
Ormat's share price increased despite decreased revenues, suggesting an anomaly that requires further investigation. It's worth considering for investment if long-term growth trend continues.
Loop Capital Downgrades$蘋果(AAPL.US)$to Hold From Buy, Price Target at $180 Apple has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $116 to $210. Citigroup Upgrades$諾福克南方(NSC.US)$to Buy From Neutral, Adjusts Price Target to $257 From $226 Norfolk Southern has an average rating of outperform and price targets ranging from $174 to $288, according to analysts ...
奧瑪特科技股票討論區
專欄US Top Rating Updates on 5/22: AAPL, NSC, CNI, ORA and More
Apple has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $116 to $210.
Citigroup Upgrades $諾福克南方(NSC.US)$to Buy From Neutral, Adjusts Price Target to $257 From $226
Norfolk Southern has an average rating of outperform and price targets ranging from $174 to $288, according to analysts ...
專欄US Top Gap Ups and Downs on 11/17: CSCO, NET, RBLX, ABNB and More
Gap Ups
1. $Bath & Body Works(BBWI.US)$ - up 7.8%
2. $勞埃德(LYG.US)$ - up 0.48%
3. $思科(CSCO.US)$ - up 0.4%
Gap Downs
1. $奧瑪特科技(ORA.US)$ - down 5.45%
2. $Cloudflare(NET.US)$ - down 3.46%
3. $Spotify Technology(SPOT.US)$ - down 2.62%
4. $Gitlab(GTLB.US)$ - dow...
專欄Today's pre-market stock movers: BBIO, LZB, ORA, DOW and more
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $輝瑞(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
暫無評論